Synthesis and analgesic activity of new pyrazole-containing derivatives of 1,2,4-triazole-3-thiol

Authors

DOI:

https://doi.org/10.14739/2409-2932.2023.3.288364

Keywords:

triazoles, pyrazole, synthesis, properties

Abstract

Pain represents a primary symptom of numerous diseases and conditions, affecting millions of people worldwide. Effective analgesic medications can alleviate or eliminate pain, thereby enhancing patients’ quality of life and assisting them in resuming normal physical and social activities. However, several existing analgesics may carry unwanted side effects, such as ulcers, blood clotting issues, drowsiness, and more. The development of new analgesics is focused on creating drugs that are both effective and associated with fewer adverse effects. Considering the continuous rise in the number of patients dealing with neurological, oncological, and other conditions accompanied by chronic pain, there is a growing demand for innovative methods of treatment and pain management. The combination of two different heterocyclic fragments within one molecule makes it possible to use the possibilities of influencing such a molecule on various mechanisms of occurrence and development of various pathological conditions, including those accompanied by pain. Chemical modifications of pyrazole and 1,2,4-triazole structures, involving their incorporation into a single molecule, have the potential, as suggested by in silico predictions, to yield biologically active compounds with analgesic properties.

The aim of this work was to determine the optimal conditions for the chemical transformation and properties of 4-amino-5-(3-methylpyrazol-5-yl)-1,2,4-triazole-3-thiol, 4-amino-5-(3-(3-fluorophenyl)pyrazol-5-yl)-1,2,4-triazole-3-thiol and their derivatives for the preparation of bioactive systems with analgesic activity.

Materials and methods. The creation of a target series of compounds was implemented by consistently using well-known methods of organic synthesis. 4-Amino-5-(3-methylpyrazole-5-yl)-1,2,4-triazole-3-thiol and 4-amino-5-(3-(3-fluorophenyl)pyrazole-5-yl)-1,2,4-triazole-3-thiol were resynthesized as starting materials using acetone or 1-(3-fluorophenyl)ethane-1-one, diethyloxalate, and sodium methylate using step-by-step hydrazinolysis and carbon disulfide involvement in an alkaline medium. Further targeted functionalization involved the introduction of a 2,6-dichlorophenyl substitute, alkane acid residues, and esters based on them into the structure of the target compounds. The structure of all synthesized substances was determined by IR spectrophotometry, 1H NMR spectroscopy, and elemental analysis. The individuality of the compounds was confirmed by high-performance liquid chromatography-mass spectrometry. The analgesic properties were studied on two models: the “acetic acid-induced writhing test” and a formalin model of pain inflammation. Pharmacokinetic parameters were predictably calculated using the SwissADME online platform.

Results. Based on the results of the synthetic part of the work, the structure of 4-amino-5-(3-methylpyrazole-5-yl)-1,2,4-triazole-3-thiol and 4-amino-5-(3-(3-fluorophenyl)pyrazole-5-yl)-1,2,4-triazole-3-thiol, as well as their derivatives, was successfully recreated. The presence of a beneficial effect of 2,6-dichlorophenyl substitute, as well as fragments of saturated carboxylic acids and their esters on the formation of antinociceptive activity has been proven. The quantitative indicators of pharmacokinetic parameters, as determined during ADME analysis, fall within acceptable ranges in nearly all instances.

Conclusions. The optimal conditions for the synthesis and structural modification of 4-amino-5-(3-methylpyrazol-5-yl)-1,2,4-triazole-3-thiol, 4-amino-5-(3-(3-fluorophenyl)pyrazol-5-yl)-1,2,4-triazole-3-thiol were established, which allowed the preparation of 2-((4-amino-5-(3-methylpyrazol-5-yl)-1,2,4-triazol-3-yl)thio)alkanoic acids and their esters, as well as [1,2,4]triazolo[3,4-b][1,3,4]thiadiazine systems. It has been shown that the combination of pyrazole derivatives of 1,2,4-triazol-3-thiol with 2,6-dichlorophenyl substituent and fragments of saturated carboxylic acids and their esters creates conditions for the formation of compounds with antinociceptive activity, which was confirmed in vivo by experimental data acetic acid-induced writhing test and formalin inflammation model.

Author Biographies

S. O. Fedotov, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

PhD-student of the Department of Natural Sciences for Foreign Students and Toxicological Chemistry

A. S. Hotsulia, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

PhD, DSc, Associate Professor of the Department of Natural Sciences for Foreign Students and Toxicological Chemistry

Yu. V. Karpenko, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

Senior Lecturer of the Department of Natural Sciences for Foreign Students and Toxicological Chemistry

References

Shcherbyna, R., Panasenko, O., Polonets, O., Nedorezanıuk, N., & Duchenko, M. (2021). Synthesis, antimicrobial and antifungal activity of ylidenhydrazides of 2-((4-R-5-R1-4Н-1,2,4-triazol-3-yl)thio)acetaldehydes. Ankara Universitesi Eczacilik Fakultesi Dergisi, 45(3), 504-514. https://doi.org/10.33483/jfpau.939418

Samelyuk, Y. G., & Kaplaushenko, A. G. (2014). Synthesis of 3-alkylthio(sulfo)-1,2,4-triazoles, containing methoxyphenyl substituents at C5atoms, their antipyretic activity, propensity to adsorption and acute toxicity. Journal of Chemical and Pharmaceutical Research, 6(5), 1117-1121.

Safonov, A. (2020). Method of synthesis novel N'-substituted 2-((5-(thiophen-2-ylmethyl)-4H-1,2,4-triazol-3-yl)thio)acetohydrazides. Journal of Faculty of Pharmacy of Ankara University, 44(2), 242-252. https://doi.org/10.33483/jfpau.580011

Gotsulya, A., Zazharskyı, V., Parchenko, V., Davydenko, P., Kulıshenko, O. & Brytanova, T. (2022). N’-(2-(5-((Theophylline-7-yl)methyl)-4-ethyl-1,2,4-triazole-3-ylthio)acetyl)isonicotinohydrazide As Antitubercular Agents. Hacettepe University Journal of the Faculty of Pharmacy, 42(3), 149-155. https://doi.org/10.52794/hujpharm.1011368

Demchenko, S., Lesyk, R., Yadlovskyi, O., Holota, S., Yarmoluk, S., Tsyhankov, S., Demchenko, A. (2023). Fused triazole-azepine hybrids as potential non-steroidal antiinflammatory agents. Scientia Pharmaceutica, 91(2), 26. https://doi.org/10.3390/scipharm91020026

Demchenko, S. A., Bobkova, L. S., & Yadlovskyi, O. E. (2021). Potentsiini protyzapalni i analhetychni zasoby v riadu pokhidnykh tryazolu: problemy ta perspektyvy [Potential anti-inflammatory and analgesic drugs from triazole derivatives line: problems and prospects]. Farmakolohiia ta likarska toksykolohiia, 15(4), 239-248. [in Ukrainian]. https://doi.org/10.33250/15.04.239

Abdellatif, K. R. A., Abdelall, E. K. A., Elshemy, H. A. H., Philoppes, J. N., Hassanein, E. H. M., & Kahk, N. M. (2021). Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and molecular modeling studies. Bioorganic chemistry, 114, 105122. https://doi.org/10.1016/j.bioorg.2021.105122

Fadaly, W. A. A., Elshaier, Y. A. M. M., Hassanein, E. H. M., & Abdellatif, K. R. A. (2020). New 1,2,4-Triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies. Bioorganic Chemistry, 98, 103752. https://doi.org/10.1016/j.bioorg.2020.103752

Bian, M., Ma, Q. Q., Wu, Y., Du, H. H., & Guo-Hua, G. (2021). Small molecule compounds with good anti-inflammatory activity reported in the literature from 01/2009 to 05/2021: a review. Journal of enzyme inhibition and medicinal chemistry, 36(1), 2139-2159. https://doi.org/10.1080/14756366.2021.1984903

Azim, T., Wasim, M., Akhtar, M. S., & Akram, I. (2021). An in vivo evaluation of anti-inflammatory, analgesic and anti-pyretic activities of newly synthesized 1, 2, 4 Triazole derivatives. BMC complementary medicine and therapies, 21(1), 304. https://doi.org/10.1186/s12906-021-03485-x

Fedotov, S. O., Hotsulia, А. S. (2021). Synthesis and properties of S-derivatives of 4-amino-5-(5-methylpyrazol-3-yl)-1,2,4-triazole-3-thiol. Current issues in pharmacy and medicine: science and practice, 14(3), 268-274. https://doi.org/10.14739/2409-2932.2021.3.243176

Fedotov, S. O., & Hotsulia, A. S. (2023). Synthesis and properties of S-alkyl 4-amino-5-(5-(3-fluorophenyl)-pyrazol-3-yl)-1,2,4-triazole-3-thiol derivatives. Current issues in pharmacy and medicine: science and practice, 16(1), 5-11. https://doi.org/10.14739/2409-2932.2023.1.273461

Fedotov, S. O., Hotsulia А. S. (2023). Synthesis and properties of 6-(2,6-dichlorophenyl)-3-(3-methyl-1H-pyrazol-5-yl)-6,7-dihydro-5H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-7-carboxylic acid and its salts. Current issues in pharmacy and medicine: science and practice. 2(42), 121-129. https://doi.org/10.14739/2409-2932.2023.2.279460

Pryimenko, A. O., Vasyliev, D. A., Kazunin, M. S., Pryimenko, B. O., Samura, I. B., & Prytula, R. L. (2015). Syntez, fizyko-khimichni vlastyvosti ta analhetychna diia amoniinykh solei 8-(hidroksymetyl)-3-metyl-1H-puryn-2,6-(3H,7H)-dionu [Synthesis, physicochemical properties and analgesic effect of ammonium salts of 8-(hydroxymethyl)-3-methyl-1H-purine-2,6-(3H,7H)-dione]. Problemy viiskovoi okhorony zdorovia, 43, 239-246. [in Ukrainian].

Stefanov, O. V. (2001). Doklinichni doslidzhennia likarskykh zasobiv. [Preclinical studies of drugs: guidelines]. Kyiv: Avitsenna. [in Ukrainian].

Yam, M. F., Loh, Y. C., Oo, C. W., & Basir, R. (2020). Overview of Neurological Mechanism of Pain Profile Used for Animal "Pain-Like" Behavioral Study with Proposed Analgesic Pathways. International journal of molecular sciences, 21(12), 4355. https://doi.org/10.3390/ijms21124355

Published

2023-11-03

How to Cite

1.
Fedotov SO, Hotsulia AS, Karpenko YV. Synthesis and analgesic activity of new pyrazole-containing derivatives of 1,2,4-triazole-3-thiol. Current issues in pharmacy and medicine: science and practice [Internet]. 2023Nov.3 [cited 2024Dec.3];16(3):205-12. Available from: http://pharmed.zsmu.edu.ua/article/view/288364